CLINICAL ROLE -
Cycloset® (bromocriptine mesylate) Tablets: A Novel Treatment for the Management of Type 2 Diabetes in Adults
Cycloset (quick-release formulation of bromocriptine mesylate), a dopamine D2 agonist, is a novel agent recently approved by the FDA for type 2 diabetes mellitus.
Read More